Your browser doesn't support javascript.
loading
External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.
Light, Alexander; Peters, Max; Reddy, Deepika; Kanthabalan, Abi; Otieno, Marjorie; Pavlou, Menelaos; Omar, Rumana; Adeleke, Sola; Giganti, Francesco; Brew-Graves, Chris; Williams, Norman R; Emara, Amr; Haroon, Athar; Latifoltojar, Arash; Sidhu, Harbir; Freeman, Alex; Orczyk, Clement; Nikapota, Ashok; Dudderidge, Tim; Hindley, Richard G; Virdi, Jaspal; Arya, Manit; Payne, Heather; Mitra, Anita V; Bomanji, Jamshed; Winkler, Mathias; Horan, Gail; Moore, Caroline; Emberton, Mark; Punwani, Shonit; Ahmed, Hashim U; Shah, Taimur T.
Affiliation
  • Light A; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Peters M; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Reddy D; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Kanthabalan A; Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Otieno M; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Pavlou M; Division of Surgery and Interventional Sciences, University College London, London, UK.
  • Omar R; Division of Surgery and Interventional Sciences, University College London, London, UK.
  • Adeleke S; Department of Statistical Science, University College London, London, UK.
  • Giganti F; Department of Statistical Science, University College London, London, UK.
  • Brew-Graves C; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Williams NR; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Emara A; Division of Surgery and Interventional Sciences, University College London, London, UK.
  • Haroon A; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK.
  • Latifoltojar A; Division of Medicine, Faculty of Medicine, University College London, London, UK.
  • Sidhu H; Division of Surgery and Interventional Sciences, University College London, London, UK.
  • Freeman A; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
  • Orczyk C; Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.
  • Nikapota A; Department of Nuclear Medicine, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
  • Dudderidge T; Division of Medicine, Faculty of Medicine, University College London, London, UK.
  • Hindley RG; Department of Radiology, Royal Marsden NHS Foundation Trust, Surrey, UK.
  • Virdi J; Division of Medicine, Faculty of Medicine, University College London, London, UK.
  • Arya M; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK.
  • Payne H; Department of Histopathology, University College London Hospital NHS Foundation Trust, London, UK.
  • Mitra AV; Division of Surgery and Interventional Sciences, University College London, London, UK.
  • Bomanji J; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
  • Winkler M; Sussex Cancer Centre, Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
  • Horan G; Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Moore C; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
  • Emberton M; Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, UK.
  • Punwani S; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Ahmed HU; Department of Histopathology, University College London Hospital NHS Foundation Trust, London, UK.
  • Shah TT; Department of Oncology, University College London Hospital NHS Foundation Trust, London, UK.
BJU Int ; 132(5): 520-530, 2023 11.
Article in En | MEDLINE | ID: mdl-37385981
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Salvage Therapy Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Salvage Therapy Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom